ArTS Archivio della ricerca di Trieste

MAGLI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 709
NA - Nord America 483
EU - Europa 155
SA - Sud America 83
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 457
SG - Singapore 326
KR - Corea 124
VN - Vietnam 118
IT - Italia 63
BR - Brasile 55
CN - Cina 43
FR - Francia 26
IN - India 25
PL - Polonia 19
AR - Argentina 18
GB - Regno Unito 16
BD - Bangladesh 13
CA - Canada 12
HK - Hong Kong 12
MX - Messico 11
FI - Finlandia 6
ES - Italia 5
IQ - Iraq 5
ID - Indonesia 4
JP - Giappone 4
NL - Olanda 4
PH - Filippine 4
PK - Pakistan 4
ZA - Sudafrica 4
AT - Austria 3
AZ - Azerbaigian 3
EC - Ecuador 3
JO - Giordania 3
PY - Paraguay 3
SA - Arabia Saudita 3
SE - Svezia 3
AL - Albania 2
CO - Colombia 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
RU - Federazione Russa 2
TH - Thailandia 2
TR - Turchia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CY - Cipro 1
DE - Germania 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
IE - Irlanda 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.444
Salva come PNG Salva come JPEG
Città #
Singapore 234
San Jose 171
Seoul 124
Ashburn 103
Ho Chi Minh City 38
Hanoi 20
Trieste 20
Beijing 18
Council Bluffs 18
New York 17
Los Angeles 16
Santa Clara 16
Chicago 15
Da Nang 13
Haiphong 12
Hong Kong 12
Zgierz 10
Warsaw 9
Denver 8
Lauterbourg 8
Milan 8
Orem 8
Montreal 6
Mumbai 6
Chennai 5
Houston 5
Lappeenranta 5
São Paulo 5
Atlanta 4
London 4
Mexico City 4
Miano 4
New Delhi 4
Poplar 4
Tokyo 4
Amman 3
Biên Hòa 3
Boydton 3
Dallas 3
Johannesburg 3
Naples 3
Querétaro 3
Stockholm 3
Albano Laziale 2
Baghdad 2
Baku 2
Boston 2
Brasília 2
Brooklyn 2
Buenos Aires 2
Campinas 2
Can Tho 2
Curitiba 2
Dhaka 2
Goiânia 2
Guangzhou 2
Hải Dương 2
Lahore 2
Manaus 2
Manchester 2
Nairobi 2
Orangeburg 2
Phoenix 2
Riyadh 2
San Donà di Piave 2
Tampa 2
Tashkent 2
Tirana 2
Toronto 2
Vitória da Conquista 2
Abaetetuba 1
Addis Ababa 1
Agadir 1
Aizawl 1
Ambato 1
Amparo 1
Amsterdam 1
Andrelândia 1
Ankara 1
Annapolis 1
Antonio Nariño 1
Arlington 1
Aryanah 1
Asunción 1
Açu 1
Baena 1
Bell Buckle 1
Belvedere 1
Bengaluru 1
Benito Juarez 1
Berazategui 1
Berrouaghia 1
Bishkek 1
Bismarck 1
Blainville 1
Boca Raton 1
Bondy 1
Bragança Paulista 1
Bridgetown 1
Burgas 1
Totale 1.066
Salva come PNG Salva come JPEG
Nome #
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 53
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? 48
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study 48
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 47
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 41
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy 38
Assessment of PTV margins accounting for prostate intrafraction motion in SBRT with online IGRT 36
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study 36
Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT 35
Adaptive radiotherapy nel trattamento radioterapico stereotassico ipofrazionato del tumore della prostata: Dose Tracking vs Re-Optimization 34
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or Gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial 33
3T-MRI in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for CT-registration 29
18F-Choline-PET-CT (PET) in N stage and radiation treatment planning (RTP) of prostate cancer patients (PCap) at High or unfavorable/intermediate risk (HUIR) 28
An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer 28
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 28
A multicenter study of the prognosis and treatment of adult brain ependymonal tumors. 28
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 27
CONTROVERSY PERSISTS OVER THE ACTUAL DOSE–VOLUME RELATIONSHIP AND INDEED WHETHER THE PENILE BULB IS JUST A SURROGATE FOR OTHER NEARBY CRITICAL STRUCTURES, ESPECIALLY GIVEN ITS LIMITED ROLE IN DEVELOPMENT AND MAINTENANCE OF ERECTIONS 26
Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT) 25
Correlation Between Dose-Volume Constraints and Late Rectum Bleeding in Patients Treated for Prostate Cancer at Dose Between 70 and 76 Gy 25
Assessment of PTV Margins Accounting for Prostate Intrafraction Motion in SBRT with Online IGRT 22
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 22
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). 22
Androgen Deprivation and Late Rectal Bleeding After Radiotherapy for Prostate Carcinoma 21
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 21
Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients 20
Breast leiomyosarcoma with myxoid aspects 20
COVID-19 outbreak and cancer radiotherapy disruption in italy: Survey endorsed by the italian association of radiotherapy and clinical oncology (AIRO) 20
Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients 19
Toxicity profile with hypofractionated RT for localized prostate cancer: compared 3D-CRT vs VMAT 17
IMRT with simultaneous integrated boost and concurrent chemiotherapy for locoregionally advanced oropharynx squamous cell carcinoma: preliminary results 16
Prospective longitudinal evaluation of quality of life after prostate cancer IMR 15
Whole-pelvic nodal irradiation with hypofractionated simultaneous integrated boost for high-risk prostate cancer: outcome and late toxicity. 15
Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study 15
Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancer 15
PATIENT-SPECIFIC QA OF IMRT PLANS BY EMPLOYING AN EPID-BASED DOSE PREDICTION ALGORITHM 15
Quality of life after whole pelvis RT for prostate cancer: results from a prospective study 15
The influence of calculation parameters on the patient-QA of p-SBRT plans with VMAT 15
Ruolo della TC/PET con 18F-colina nella stadiazione linfonodale e planning radioterapico nei pazienti con carcinoma della prostate a rischio alto ed intermedio sfavorevole 14
In prostate cancer patients (PC), PET-CT 18F-choline (FC) can incidentally discover un related diseases: our experience in 573 cases 14
MRI-guided contouring in SBRT of the prostate for localized disease 14
QUALITY INDICATORS OF INTENSITY MODULATED-IMAGE GUIDED RADIOTHERAPY (IM-IGRT) CONCOMITANT TO CHEMOTHERAPY (CT): A BENCH-MARKING ANALYSIS FOR CLINICAL AND TECHNICAL GOVERNANCE 14
Tecnologie integrate nel trattamento oncologico dei tumori Head & Neck Innovazioni della radioterapia di interesse ORL 14
Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study 14
Radioterapia Oncologica 13
SALVAGE ELECTIVE PELVIC NODAL IRRADIATION (ENRT) COMBINED WITH FOCAL NODAL STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN THE NODAL METACHRONOUS OLIGOMETASTATIC CASTRATION-NAIVE PROSTATE CANCER: A TWOINSTITUTION EXPERIENCE 13
Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer 13
Predictors of Rectal Acute Toxicity in High-Dose 3D-CRT for Prostate Cancer. Results From a Prospective Multi-Centric Study Performed by the AIRO National Working Group on Prostate Irradiation 13
DEVELOPMENT OF A SET OF NOMOGRAMS TO PREDICT ACUTE LOWER GASTROINTESTINAL TOXICITY FOR PROSTATE CANCER 3D-CRT 13
SBRT for Prostate Cancer in 3 fractions: Acute Toxicity Rates from a Prospective Multicenter Study 13
Unscheduled presentations of urological cancer outpatients in an oncology clinic: a single institution retrospective study 13
Retrospective assessment of treatment planning quality in prostate SBRT 12
Dose-effect relationship for 1-year incontinence after post-prostatectomy intensitymodulated radiotherapy (MRT) 12
Radioterapia stereotassica body (42Gy in 7 frazioni settimanali) nei tumori localizzati della prostata: valutazioni radiobiologiche e primi risultati 12
STEREOTACTIC BODY RADIOTHERAPY FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER. TOXICITY RESULTS OF PHASE II STUDY 12
Il ruolo della radioterapia nel linfoma di Hodgkin: luci e ombre agli arbori del XXI secolo 12
The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study 12
Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer 12
IGRT con 3D-CRT ipofrazionata nel carcinoma prostatico a rischio intermedio mediante marcatori fiduciali intraprostatici: risultati di studio di fase II 11
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial. 11
Stereobody radiotherapy (42Gy/7fx) for localized prostate cancer: radiobiology and first results 11
Image-guided hypofractionated radiotherapy for localized prostate cancer with 42Gy in 7 fractions: radiobiogy and preliminary clinical results of a phase II study 11
PREDICTORS FOR RECTAL AND INTESTINAL ACUTE TOXICITIES DURING PROSTATE CANCER HIGH-DOSE 3D-CRT: RESULTS OF A PROSPECTIVE MULTICENTER STUDY 10
Le metastasi cerebrali: aspetti diagnostici e terapeutici 10
FDG-PET/CT for target volume delineation in the intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and concurrent chemotherapy (CHT) for locoregionally advanced oropharynx squamous cell carcinoma: preliminary resuls 10
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions 10
Linee guida carcinoma della prostata. AIOM edizione 2019 10
Laryngeal long-term morbility after supreglottic laryngectomy and postoperative radiation therapy 10
La radioterapia nel trattamento degli adenomi ipofisari: risultati e prospettive 10
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: A multicenter study 10
Erectile dysfunction after prostate three-dimensional conformal radiation therapy: correlation with the dose to the bulb of the penis 10
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 9
PRACTICE PATTERNS FOR PROSTATE CANCER IN NINE CENTRAL AND NORTHERN ITALY RADIATION ONCOLOGY CENTERS: A SURVEY INCLUDING 1759 PATIENTS TREATED DURING TWO DECADES (1980–1998) 9
Il ruolo della radioterapia nel trattamento integrato del carcinoma del retto e giunzione retto-sigma 9
Irradiazione pelvica con tecnica IMRT-SIB nei pazienti con tumour della prostate ad alto rischio: risultati di studio di fase II 9
IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study 9
PET/CT FOR TREATING LOCOREGIONALLY ADVANCED OROPHARYNX SQUAMOUS CELL CARCINOMA WITH IMRT-SIB AND CHT 9
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study 9
Phase-II study of sbrt for localized prostate cancer: outcome and late toxicity 8
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 8
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 8
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 7
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 7
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort 6
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 6
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial. 6
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study 6
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer 6
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 6
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 3
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water! 3
Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence 3
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 3
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT 3
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 3
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 3
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 3
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 3
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 3
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors 3
Totale 1.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20261.591 0 0 0 254 162 223 83 74 375 420 0 0
Totale 1.591